Stock Watch: Bad Deals Backfire On Bayer And CSL
Acquisition Woes Hit Stocks After Earnings Announcements
As the pharma earnings season wrapped up, it seemed like a contest to see which company's stock price dropped the most after their announcement and which made the poorest acquisition.
